Emma O'Dowd

Contact

• workDavid Evans Building
  Nottingham City Hospital
  Hucknall Road
  Nottingham
  NG5 1PB
  UK
• work01159249924
• Emma.Odowd@nottingham.ac.uk

Biography

Dr Emma O'Dowd is a consultant respiratory physician at Nottingham University Hospitals NHS Trust. She was awarded a PhD entitled Factors influencing the diagnosis and subsequent prognosis in patients with lung cancer in April 2017 funded by the Roy Castle Lung Cancer Foundation. Her research interests are lung cancer screening and early diagnosis of lung cancer. She is a member of the British Thoracic Society Lung Cancer & Mesothelioma Advisory Group, Lung Cancer Clinical Expert Group and the IASLC Tobacco Control and Smoking Cessation Committee.

Expertise Summary

Lung cancer screening

Early diagnosis of lung cancer

Research Summary

Grants

1. SELECT Selection of Eligible People for Lung Cancer Screening using Electronic Primary Care DaTa: Development of new risk prediction models. Cancer Research UK. Co-applicant. £358,737 (2018-2023)
2. 4-IN-THE-LUNG-RUN Towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening): A Randomised Comparison of Personalised Lung Cancer Screening Regimens. Horizon 20:20. Co-applicant. €7,999,787 (2020-2024)
3. DECLINE: DEcisions against Curative treatment for Lung cancer IN Eligible patients. Roy Castle Lung Cancer Foundation. Principal applicant. £210,810. (2020-2023)
4. Use of virtual reality to deliver prehabilitation in patients undergoing lung cancer surgery. NHSX. Co-Principal applicant. £144,000. (2022-2024)

Recent Publications

• VAN MEERBEECK J, O'DOWD E, WARD B, VAN SCHILL P and SNOECKX A, 2022. Lung Cancer Screening: New Perspective and Challenges in Europe Cancers. 14(9), 2343
• MORGAN H, BALDWIN D, HUBBARD R, NAVANI N, WEST D and O'DOWD E, 2022. Ninety-day mortality following lung cancer surgery: outcomes from the English national clinical outcomes audit Thorax.
• BURZIC A, O'DOWD E and BALDWIN D, 2022. The Future of Lung Cancer Screening: Current Challenges and Research Priorities Cancer Manag Res.
• O'DOWD E and BALDWIN D, 2022. In: Encyclopedia of Respiratory Medicine (Second Edition): Clinical Presentation and Diagnostic Approach in Suspected Lung Cancer 705/715

• View all publications

• VAN MEERBEECK J, O'DOWD E, WARD B, VAN SCHILL P and SNOECKX A, 2022. Lung Cancer Screening: New Perspective and Challenges in Europe Cancers. 14(9), 2343
• MORGAN H, BALDWIN D, HUBBARD R, NAVANI N, WEST D and O'DOWD E, 2022. Ninety-day mortality following lung cancer surgery: outcomes from the English national clinical outcomes audit Thorax.
• BURZIC A, O'DOWD E and BALDWIN D, 2022. The Future of Lung Cancer Screening: Current Challenges and Research Priorities Cancer Manag Res.
• O'DOWD E and BALDWIN D, 2022. In: Encyclopedia of Respiratory Medicine (Second Edition): Clinical Presentation and Diagnostic Approach in Suspected Lung Cancer 705/715
• BALDWIN D, CALLISTER M, CROSBIE P, O'DOWD E, RINTOUL R, ROBBINS H and STEELE R, 2021. Biomarkers in lung cancer screening: the importance of study design European Respiratory Journal. 57(1),
• ALZUBAIDI A, KAUR J, MAHMUD M, BROWN D, HE J, BALL G, BALDWIN D, O'DOWD E and HUBBARD R, 2021. Selecting Lung Cancer Patients from UK Primary Care Data: A Longitudinal Study of Feature Trends Applied Intelligence and Informatics.
• MORGAN H, ELLIS L, O'DOWD E, MURRAY R, HUBBARD R and BALDWIN D, 2021. What is the Definition of Cure in Non-small Cell Lung Cancer? Oncol Ther.
• BALATA H, RUPAREL M, O'DOWD E, LEDSON M, FIELD J, DUFFY S, QUAIFE S, SHARMAN A, JANES S, BALDWIN D, BOOTON R and CROSBIE P, 2021. Analysis of the baseline performance of five UK lung cancer screening programmes Lung Cancer. 136-140
• O'DOWD E, TEN HAAF K, KAUR J, DUFFY S, HAMILTON W, HUBBARD R, FIELD J, CALLISTER M, JANES S, DE KONING H, RAWLINSON J and BALDWIN D, 2021. Selection of eligible participants for screening for lung cancer using primary care data Thorax.
• BALDWIN DR, GUSTAFSON J, PICKUP L, ARTETA C, NOVOTNY P, DECLERCK J, KADIR T, FIGUEIRAS C, STERBA A, EXELL A, POTESIL V, HOLLAND P, SPENCE H, CLUBLEY A, O'DOWD E, CLARK M, ASHFORD-TURNER V, CALLISTER ME and GLEESON FV, 2020. External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules. Thorax. 75(4), 306-312
• MORGAN H, O'DOWD E, NAIR A and BALDWIN D, 2020. New fissure-attached nodules in lung cancer screening: more practical implications from the NELSON study? Translational Lung Cancer Research.
• BALDWIN D, O'DOWD E and TEN HAAF K, 2020. Targeted screening for lung cancer is here but who do we target and how? Thorax. 75(8),
• CRISP E, O'DOWD E and BALDWIN D, 2020. Diagnosis and management of malignant pleural mesothelioma Practitioner. 1843
• RUPAREL M, QUAIFE SL, DICKSON JL, HORST C, BURKE S, TAYLOR M, AHMED A, SHAW P, SOO MJ, NAIR A, DEVARAJ A, O'DOWD EL, BHOWMIK A, NAVANI N, SENNETT K, DUFFY SW, BALDWIN DR, SOFAT R, PATEL RS, HINGORANI A and JANES SM, 2019. Evaluation of cardiovascular risk in a lung cancer screening cohort. Thorax. 74(12), 1140-1146
• O'DOWD E and TEN HAAF K, 2019. Lung cancer screening: enhancing risk stratification and minimising harms by incorporating information from screening results Thorax.
• MORGAN H, O'DOWD E and BALDWIN D, 2019. Time to diagnosis key in improving lung cancer outcomes Practitioner. 263, 21-25
• HOWARD L, BARDEN S, CONDLIFFE R, CONNOLLY V, DAVIES C, DONALDSON J, EVERETT B, FREE C, HORNER D, HUNTER L, KALER J, NELSON-PIERCY C, O'DOWD E, PATEL R, PRESTON W, SHEARES K and TAIT C, 2018. British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE) Thorax.
• HOWARD L, BARDEN S, CONDLIFFE R, CONNOLLY V, DAVIES C, DONALDSON J, EVERETT B, FREE C, HORNER D, HUNTER L, KALER J, NELSON-PIERCY C, O'DOWD E, PATEL R, PRESTON W, SHEARES K and TAIT C, 2018. British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism BMJ Open Resp Res.
• O'DOWD EL and BALDWIN DR, 2017. Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps. The British journal of radiology. 20170460
• O'DOWD EL, MCKEEVER TM, BALDWIN DR and HUBBARD RB, 2016. Place of Death in Patients with Lung Cancer: A Retrospective Cohort Study from 2004-2013. PloS one. 11(8), e0161399
• O'DOWD EL, LÜCHTENBORG M, BALDWIN DR, MCKEEVER TM, POWELL HA, MØLLER H, JAKOBSEN E and HUBBARD RB, 2016. Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countries. Lung cancer (Amsterdam, Netherlands). 95, 88-93
• K CUSWORTH, E O'DOWD, R HUBBARD, P BECKETT, M D PEAKE and I WOOLHOUSE, 2015. Variation in lung cancer resources and workload: results from the first national lung cancer organisational audit Thorax.
• E O'DOWD and D BALDWIN, 2015. Screening for lung cancer. Br J Hosp Med (Lond). 76(6), C89-93
• O'DOWD EL, MCKEEVER TM, BALDWIN DR, ANWAR S, POWELL HA, GIBSON JE, IYEN-OMOFOMAN B and HUBBARD RB, 2015. Author's response: What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? Thorax. 70(2), 185
• O'DOWD EL and BALDWIN DR, 2015. Early diagnosis pivotal to survival in lung cancer. The Practitioner. 258(1776), 21-4, 2-3
• O'DOWD E and BALDWIN D, 2015. Screening for lung cancer. British journal of hospital medicine (London, England : 2005). 76(6), C89-93
• CUSWORTH K, O'DOWD E, HUBBARD R, BECKETT P, PEAKE MD and WOOLHOUSE I, 2015. Variation in lung cancer resources and workload: results from the first national lung cancer organisational audit. Thorax. 70(10), 1001-3
• O'DOWD EL, MCKEEVER TM, BALDWIN DR, ANWAR S, POWELL HA, GIBSON JE, IYEN-OMOFOMAN B and HUBBARD RB, 2014. What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK? Thorax. 70(2), 161-8
• BALDWIN DR and O'DOWD EL, 2014. Next steps and barriers to implementing lung cancer screening with low-dose CT. The British journal of radiology. 87(1044), 20140416
• O'DOWD EL, KUMARAN M, ANWAR S, PALOMO B and BALDWIN DR, 2014. Brain metastases following radical surgical treatment of non-small cell lung cancer: is preoperative brain imaging important? Lung cancer (Amsterdam, Netherlands). 86(2), 185-9